Ep. 90: Unlimited Bio’s Journey to Launch a Prospera Biotech Company - with Ivan Morgunov & Dr. Anna Vakhrusheva
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Ivan Morgunov is an experienced entrepreneur driven by the goal of stopping aging. He founded Longaevus Technologies, a venture studio in the field of longevity, and Unlimited Bio—one of the two companies that administer genetic therapies in Prospera Dr. Anna Vakhrusheva has over a decade of experience in advancing vaccines and gene therapies. She led the development of Russia’s first recombinant SARS-CoV-2 vaccine (Betuvax JSC), driving it from R&D to clinical trials within two years. As a co-founder of Unlimited Bio, she spearheads genetic therapy research, translating cutting-edge science into real-world longevity solutions.
In this episode, Anna & Ivan describe their journey to start a biotech company in Prospera, their novel thesis on why business model innovation matters to solve aging, the opportunity of “cocktail therapies”, regulatory fast-track options and challenges in a new jurisdiction.
Explore Infinita City:
* Explore the Archive: The Infinita City Times
* Join the Builders’ Hub on Telegram
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com